hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts

Background. Intestinal fibrosis, one of the complications of inflammatory bowel disease (IBD), is associated with fistula and intestinal stricture formation. There are currently no treatments for fibrosis. Mesenchymal stem cell-derived exosomes have been proven to exert inhibitory and reversal effec...

Full description

Saved in:
Bibliographic Details
Main Authors: Yifei Wang, Yaqin Zhang, Bing Lu, Jianbo Xi, Dickson Kofi Wiredu Ocansey, Fei Mao, Donglin Hao, Yongmin Yan
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2023/2828981
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832548843762221056
author Yifei Wang
Yaqin Zhang
Bing Lu
Jianbo Xi
Dickson Kofi Wiredu Ocansey
Fei Mao
Donglin Hao
Yongmin Yan
author_facet Yifei Wang
Yaqin Zhang
Bing Lu
Jianbo Xi
Dickson Kofi Wiredu Ocansey
Fei Mao
Donglin Hao
Yongmin Yan
author_sort Yifei Wang
collection DOAJ
description Background. Intestinal fibrosis, one of the complications of inflammatory bowel disease (IBD), is associated with fistula and intestinal stricture formation. There are currently no treatments for fibrosis. Mesenchymal stem cell-derived exosomes have been proven to exert inhibitory and reversal effects in IBD and other organ fibrosis. In this study, we explored the role of human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-Ex) in IBD-related fibrosis and its associated mechanism to provide new ideas for the prevention and treatment of IBD-related intestinal fibrosis. Methods. We established a DSS-induced mouse IBD-related intestinal fibrosis model and observed the effect of hucMSC-Ex on the mouse model. We also used the TGF-induced human intestinal fibroblast CCD-18Co to observe the role of hucMSC-Ex in the proliferation, migration, and activation of intestinal fibroblasts. Having observed that the extracellular-signal-regulated kinase (ERK) pathway in intestinal fibrosis can be inhibited by hucMSC-Ex, we treated intestinal fibroblasts with an ERK inhibitor to emphasize the potential target of ERK phosphorylation in the treatment of IBD-associated intestinal fibrosis. Results. In the animal model of IBD-related fibrosis, hucMSC-Ex alleviated inflammation-related fibrosis as evident in the thinning of the mice’s intestinal wall and decreased expression of related molecules. Moreover, hucMSC-Ex inhibited TGF-β-induced proliferation, migration, and activation of human intestinal fibroblasts, and ERK phosphorylation played a key role in IBD-associated fibrosis. The inhibition of ERK decreased the expression of fibrosis-related indicators such as α-SMA, fibronectin, and collagen I. Conclusion. hucMSC-Ex alleviates DSS-induced IBD-related intestinal fibrosis by inhibiting profibrotic molecules and intestinal fibroblast proliferation and migration by decreasing ERK phosphorylation.
format Article
id doaj-art-bd9dbcc6504d442b9b727206f73de326
institution Kabale University
issn 1687-9678
language English
publishDate 2023-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-bd9dbcc6504d442b9b727206f73de3262025-02-03T06:12:58ZengWileyStem Cells International1687-96782023-01-01202310.1155/2023/2828981hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal FibroblastsYifei Wang0Yaqin Zhang1Bing Lu2Jianbo Xi3Dickson Kofi Wiredu Ocansey4Fei Mao5Donglin Hao6Yongmin Yan7Wujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityZhenjiang CollegeWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityWujin Institute of Molecular Diagnostics and Precision Cancer Medicine of Jiangsu UniversityBackground. Intestinal fibrosis, one of the complications of inflammatory bowel disease (IBD), is associated with fistula and intestinal stricture formation. There are currently no treatments for fibrosis. Mesenchymal stem cell-derived exosomes have been proven to exert inhibitory and reversal effects in IBD and other organ fibrosis. In this study, we explored the role of human umbilical cord mesenchymal stem cell-derived exosomes (hucMSC-Ex) in IBD-related fibrosis and its associated mechanism to provide new ideas for the prevention and treatment of IBD-related intestinal fibrosis. Methods. We established a DSS-induced mouse IBD-related intestinal fibrosis model and observed the effect of hucMSC-Ex on the mouse model. We also used the TGF-induced human intestinal fibroblast CCD-18Co to observe the role of hucMSC-Ex in the proliferation, migration, and activation of intestinal fibroblasts. Having observed that the extracellular-signal-regulated kinase (ERK) pathway in intestinal fibrosis can be inhibited by hucMSC-Ex, we treated intestinal fibroblasts with an ERK inhibitor to emphasize the potential target of ERK phosphorylation in the treatment of IBD-associated intestinal fibrosis. Results. In the animal model of IBD-related fibrosis, hucMSC-Ex alleviated inflammation-related fibrosis as evident in the thinning of the mice’s intestinal wall and decreased expression of related molecules. Moreover, hucMSC-Ex inhibited TGF-β-induced proliferation, migration, and activation of human intestinal fibroblasts, and ERK phosphorylation played a key role in IBD-associated fibrosis. The inhibition of ERK decreased the expression of fibrosis-related indicators such as α-SMA, fibronectin, and collagen I. Conclusion. hucMSC-Ex alleviates DSS-induced IBD-related intestinal fibrosis by inhibiting profibrotic molecules and intestinal fibroblast proliferation and migration by decreasing ERK phosphorylation.http://dx.doi.org/10.1155/2023/2828981
spellingShingle Yifei Wang
Yaqin Zhang
Bing Lu
Jianbo Xi
Dickson Kofi Wiredu Ocansey
Fei Mao
Donglin Hao
Yongmin Yan
hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
Stem Cells International
title hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
title_full hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
title_fullStr hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
title_full_unstemmed hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
title_short hucMSC-Ex Alleviates IBD-Associated Intestinal Fibrosis by Inhibiting ERK Phosphorylation in Intestinal Fibroblasts
title_sort hucmsc ex alleviates ibd associated intestinal fibrosis by inhibiting erk phosphorylation in intestinal fibroblasts
url http://dx.doi.org/10.1155/2023/2828981
work_keys_str_mv AT yifeiwang hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT yaqinzhang hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT binglu hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT jianboxi hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT dicksonkofiwireduocansey hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT feimao hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT donglinhao hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts
AT yongminyan hucmscexalleviatesibdassociatedintestinalfibrosisbyinhibitingerkphosphorylationinintestinalfibroblasts